Filing Details
- Accession Number:
- 0001225208-18-003775
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-22 16:33:00
- Reporting Period:
- 2018-02-20
- Accepted Time:
- 2018-02-22 16:33:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 21665 | Colgate Palmolive Co | CL | Perfumes, Cosmetics & Other Toilet Preparations (2844) | 131815595 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1333720 | B Daniel Marsili | C/O Colgate-Palmolive Company 300 Park Avenue New York NY 10022 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-20 | 3,012 | $70.19 | 61,115 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-21 | 2,680 | $70.19 | 58,435 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 28,802 | Indirect | By Issuer's 401(k) Plan Trustee |
Footnotes
- Sale of shares with proceeds delivered to the issuer for payment of tax liability incident to vesting of a restricted stock unit award under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Weighted average price, as these shares were sold in multiple transactions at prices ranging from $69.97 to $70.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
